Jaguar Health (JAGX) Stock Forecast, Price & News

Jaguar Health (NASDAQ:JAGX) Frequently Asked Questions

Is Jaguar Health a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Jaguar Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Jaguar Health stock.
View analyst ratings for Jaguar Health or view top-rated stocks.

Are investors shorting Jaguar Health?

Jaguar Health saw a drop in short interest in April. As of April 30th, there was short interest totaling 3,450,000 shares, a drop of 22.5% from the April 15th total of 4,450,000 shares. Based on an average daily trading volume, of 4,250,000 shares, the short-interest ratio is currently 0.8 days. Approximately 4.9% of the shares of the stock are short sold.
View Jaguar Health's Short Interest.

When is Jaguar Health's next earnings date?

Jaguar Health is scheduled to release its next quarterly earnings announcement on Friday, August 12th 2022.
View our earnings forecast for Jaguar Health.

How were Jaguar Health's earnings last quarter?

Jaguar Health, Inc. (NASDAQ:JAGX) issued its quarterly earnings data on Tuesday, May, 10th. The biotechnology company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.19. Jaguar Health had a negative trailing twelve-month return on equity of 319.63% and a negative net margin of 1,023.99%. During the same quarter in the previous year, the business posted ($0.30) earnings per share.
View Jaguar Health's earnings history.

When did Jaguar Health's stock split? How did Jaguar Health's stock split work?

Jaguar Health shares reverse split before market open on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 8th 2021. An investor that had 100 shares of Jaguar Health stock prior to the reverse split would have 33 shares after the split.

What price target have analysts set for JAGX?

1 Wall Street analysts have issued 1 year price objectives for Jaguar Health's stock. Their forecasts range from $5.00 to $5.00. On average, they expect Jaguar Health's stock price to reach $5.00 in the next year. This suggests a possible upside of 1,153.8% from the stock's current price.
View analysts' price targets for Jaguar Health or view top-rated stocks among Wall Street analysts.

Who are Jaguar Health's key executives?

Jaguar Health's management team includes the following people:

• Ms. Lisa A. Conte, Founder, CEO, Pres & Director (Age 63, Pay $525.21k)
• Mr. Jonathan S. Wolin CPA, J.D., M.B.A., Chief of Staff, Chief Compliance Officer & Gen. Counsel (Age 60, Pay $336.51k)
• Dr. Steven R. King, Chief Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec. (Age 64, Pay $332.23k)
• Ms. Carol R. Lizak, Chief Financial Officer (Age 58)
• Dr. Pravin R. Chaturvedi Ph.D., Chief Scientific Officer & Chair of Scientific Advisory Board (Age 59)
• Mr. Peter Hodge, Sr. Director of Investor Relations, Bus. Devel. & Special Events
• Dr. Karen J. Brunke Ph.D., Exec. VP of Corp. & Bus. Devel.
• Mr. David Sesin, Chief Manufacturing Officer
• Mr. Ian H. Wendt M.B.A., Chief Commercial Officer
• Dr. Michael K. Guy D.V.M., M.S., Ph.D., VP of Preclinical & Nonclinical Studies

Who are some of Jaguar Health's key competitors?

Some companies that are related to Jaguar Health include Applied Molecular Transport (AMTI), Nabriva Therapeutics (NBRV), Atossa Therapeutics (ATOS), Selecta Biosciences (SELB), ProPhase Labs (PRPH), Cue Biopharma (CUE), MediciNova (MNOV), Immuneering (IMRX), RVL Pharmaceuticals (RVLP), Greenwich LifeSciences (GLSI), 9 Meters Biopharma (NMTR), Otonomy (OTIC), Endo International (ENDP), Alaunos Therapeutics (TCRT) and Vascular Biogenics (VBLT).
View all of JAGX's competitors.

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?

(JAGX) raised $22 million in an initial public offering (IPO) on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

Who are Jaguar Health's major shareholders?

Jaguar Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (1.98%), Vanguard Group Inc. (1.40%), Virtu Financial LLC (0.30%), Bank of New York Mellon Corp (0.22%), Principal Financial Group Inc. (0.15%) and Goldman Sachs Group Inc. (0.07%).
View institutional ownership trends for Jaguar Health.

Which major investors are selling Jaguar Health stock?

JAGX stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Principal Financial Group Inc., and Group One Trading L.P..
View insider buying and selling activity for Jaguar Health or view top insider-selling stocks.

Which major investors are buying Jaguar Health stock?

JAGX stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Bank of New York Mellon Corp, Virtu Financial LLC, Citigroup Inc., and Goldman Sachs Group Inc..
View insider buying and selling activity for Jaguar Health or or view top insider-buying stocks.

How do I buy shares of Jaguar Health?

Shares of JAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $0.40.

How much money does Jaguar Health make?

Jaguar Health has a market capitalization of $30.73 million and generates $4.34 million in revenue each year. The biotechnology company earns $-52.60 million in net income (profit) each year or ($1.280040) on an earnings per share basis.

How many employees does Jaguar Health have?

Jaguar Health employs 52 workers across the globe.

What is Jaguar Health's official website?

The official website for Jaguar Health is www.jaguaranimalhealth.com.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company can be reached via phone at (415) 371-8300.